U.S. Markets closed

How Alexion Could Diversify From Its Cash Cow To Battle Valeant, Teva

ALLISON GATLIN
How Alexion Could Diversify From Its Cash Cow To Battle Valeant, Teva

Alexion Pharmaceuticals will snap up Wilson Therapeutics in a move that helps it diversify from its blockbuster franchise and compete with Valeant and Teva.